Mangalam Drugs & Organics Stock Screener | Share Price & Fundamental Analysis
MANGALAM
Pharmaceuticals
Share Price NSE
₹29.27
▲
1.39 (4.99%)
Share Price BSE
₹31.62
▼
-1.55 (-4.67%)
Track Mangalam Drugs & Organics share price live with TickJournal's free stock screener.
Analyze Mangalam Drugs & Organics share price history trends and compare 52-week high low
levels.
Calculate MANGALAM stock fair value using fundamental analysis and view live share price charts.
Determine Mangalam Drugs & Organics share intrinsic value and compare it with current MANGALAM share price.
Record your Mangalam Drugs & Organics trades in TickJournal's free trading journal and track your portfolio performance.
Mangalam Drugs & Organics Market Cap
₹37.99 Cr.
MANGALAM P/E Ratio (TTM)
15.00
EPS (TTM)
₹4.25
Dividend Yield
-
Debt to Equity
0.73
MANGALAM 52 Week High
₹92.46
Mangalam Drugs & Organics 52 Week Low
₹23.78
Operating Margin
14.00%
Profit Margin
-
MANGALAM Revenue (TTM)
₹73.00
EBITDA
₹10.00
Net Income
-
Total Assets
₹366.00
Total Equity
₹149.00
Mangalam Drugs & Organics Share Price History - Stock Screener Chart
Screen MANGALAM historical share price movements with interactive charts. Analyze price trends and patterns.
Mangalam Drugs & Organics Company Profile - Fundamental Screener
Screen Mangalam Drugs & Organics company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MANGALAM shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE584F01014
Mangalam Drugs & Organics Balance Sheet Screener
Screen MANGALAM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 |
|---|---|---|
| Assets | ||
| Total Assets | 366 | 334 |
| Current Assets | 199 | 176 |
| Fixed Assets | 163 | 148 |
| Liabilities | ||
| Total Liabilities | 366 | 334 |
| Current Liabilities | 26 | 34 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 149 | 136 |
| Share Capital | 16 | 16 |
| Reserves & Surplus | 133 | 120 |
Mangalam Drugs & Organics Income Statement Screener - Profit & Revenue Analysis
Screen Mangalam Drugs & Organics income statement and profit fundamentals.
Analyze MANGALAM quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Mangalam Drugs & Organics share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Revenue | 73 | 57 | 49 | 102 | 77 | 80 | 89 | 97 |
| Expenses | 63 | 62 | 52 | 91 | 68 | 71 | 80 | 90 |
| EBITDA | 10 | -5 | -3 | 12 | 8 | 9 | 9 | 7 |
| Operating Profit % | 14.00% | -8.00% | -6.00% | 11.00% | 11.00% | 11.00% | 10.00% | 7.00% |
| Depreciation | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 4 |
| Interest | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 3 |
| Profit Before Tax | 2 | -13 | -13 | 4 | 1 | 1 | 1 | 0 |
| Tax | 2 | 1 | -5 | 0 | -2 | -2 | 0 | -1 |
| Net Profit | 0 | -14 | -7 | 4 | 3 | 3 | 1 | 1 |
| EPS | 0.04 | -8.72 | -4.64 | 2.23 | 1.70 | 1.70 | 0.81 | 0.31 |
Mangalam Drugs & Organics Cash Flow Screener - Liquidity Fundamentals
Screen MANGALAM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March |
|---|---|---|
| Operating Activities | 43 | 4 |
| Investing Activities | -20 | -12 |
| Financing Activities | -22 | 5 |
| Net Cash Flow | 1 | -3 |
Mangalam Drugs & Organics Shareholding Pattern Screener
See Mangalam Drugs & Organics shareholding pattern with promoter, FII, and DII holdings.
Check Mangalam Drugs & Organics promoter holding and ownership changes for MANGALAM on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 50.30% | 50.30% | 50.30% | 50.32% | 50.32% | 50.30% | 50.30% | 50.32% |
| FII Holding | 0.47% | 0.53% | 0.11% | 0.26% | 0.21% | 0.11% | 0.11% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 44.55% | 44.53% | 45.00% | 44.22% | 44.70% | 44.91% | 44.78% | 44.22% |
| Other Holding | 4.68% | 4.63% | 4.59% | 5.20% | 4.77% | 4.67% | 4.80% | 5.46% |
| Shareholder Count | 19,697 | 19,728 | 19,881 | 19,173 | 19,312 | 19,508 | 19,679 | 17,943 |
Mangalam Drugs & Organics Share Dividend Screener - Share Yield Analysis
Check Mangalam Drugs & Organics dividend history with payout and yield data.
View Mangalam Drugs & Organics dividend details including ex-dates and amounts for MANGALAM stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.50 | 0.92% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
Mangalam Drugs & Organics Stock Index Membership
See which indices include Mangalam Drugs & Organics stock.
Check MANGALAM index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Mangalam Drugs & Organics Market Events Screener - Corporate Actions
Get Mangalam Drugs & Organics corporate actions including splits, bonuses, and buybacks.
Check Mangalam Drugs & Organics stock events that may affect MANGALAM share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -7.92% | ||
| Annual General Meeting | NA | -4.57% | ||
| 2025-11-20 | 2025-11-20 | Quarterly Result Announcement | NA | -17.31% |
| 2025-08-12 | 2025-08-12 | Extraordinary General Meeting | NA | -9.85% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -4.03% |
| 2025-05-17 | 2025-05-17 | Quarterly Result Announcement | NA | 4.63% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | 1.61% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.83% |
Mangalam Drugs & Organics Competitors Screener - Peer Comparison
Screen MANGALAM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Mangalam Drugs & Organics Company Announcements - News Screener
Screen MANGALAM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-25 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | View |
| 2025-11-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-20 | Declaration Of Un-Audited Financial Results For The Quarter Ended 30Th September 2025 | View |
| 2025-11-20 | Board Meeting Outcome for Intimation Of Outcome Of Board Meeting Held On 20Th November 2025 At 12:00 P.M. To Approve Standalone And Consolidated Un-Audited Financial Results For The Quarter Ended 30Th September 2025 | View |
| 2025-11-18 | Defaults under Para A sub-paragraph 6 of Schedule III-Initial Disclosure | View |
| 2025-11-13 | Results-Delay in Financial Results | View |
| 2025-11-13 | Board Meeting Intimation for Postponement Of Board Meeting To Be Held On 20Th November 2025 | View |
| 2025-11-11 | Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011. | View |
| 2025-11-05 | Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday 13Th November 2025 To Consider And Approve Un-Audited Financial Results(Standalone And Consolidated) For The Quarter Ended 30Th September 2025. | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-10-15 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-10-15 | Announcement under Regulation 30 (LODR)-Scheme of Arrangement | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-19 | Announcement Under Regulation 30 Of SEBI(LODR)Regulations 2015 For Submission Of Corrigendum For 52Nd Annual Report Of 2024-25. | View |
| 2025-09-10 | Reg. 34 (1) Annual Report. | View |